This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Krzysztof Regulski
Head of CMC Project Management at GenSight Biologics, France


Krzysztof Regulski, PhD, is a CMC Manager at GenSight Biologics. He manages CMC activities and leads Process Development of GS030 Product associated to optogenetic therapy for retinitis pigmentosa. He has been working in biotechnology industry since 2007, having experience in Bioprocess and QC Methods Development & Validation, Technology Transfer to CMO’s and Project Management. Before joining GenSight Biologics, Dr. Regulski was formerly Head of Bioprocess and Analytical Development at Pherecydes Pharma (Romainville, France). He received his Master’s degree in Industrial Biotechnology from Poznan University of Life Sciences (Poland) and a PhD in Biochemistry and Microbiology from University of Paris-Sud (France).